Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.
- 1 November 2003
- journal article
- review article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 111 (15) , 1827-1834
- https://doi.org/10.1289/ehp.6327
Abstract
The pathobiology of chronic beryllium disease (CBD) involves the major histocompatibility complex class II human leukocyte antigen (HLA). Although occupational exposure to beryllium is the cause of CBD, molecular epidemiologic studies suggest that specific (Italic)HLA-DPB1(/Italic) alleles may be genetic susceptibility factors. We have studied three-dimensional structural models of HLA-DP proteins encoded by these genes. The extracellular domains of HLA-DPA1*0103/B1*1701, *1901, *0201, and *0401, and HLA-DPA1*0201/B1*1701, *1901, *0201, and *0401 were modeled from the X-ray coordinates of an HLA-DR template. Using these models, the electrostatic potential at the molecular surface of each HLA-DP was calculated and compared. These comparisons identify specific characteristics in the vicinity of the antigen-binding pocket that distinguish the different HLA-DP allotypes. Differences in electrostatics originate from the shape, specific disposition, and variation in the negatively charged groups around the pocket. The more negative the pocket potential, the greater the odds of developing CBD estimated from reported epidemiologic studies. Adverse impact is caused by charged substitutions in positions 55, 56, 69, 84, and 85, namely, the exact same loci identified as genetic markers of CBD susceptibility as well as cobalt-lung hard metal disease. These findings suggest that certain substitutions may promote an involuntary cation-binding site within a putatively metal-free peptide-binding pocket and therefore change the innate specificity of antigen recognition.Keywords
This publication has 27 references indexed in Scilit:
- Genetic Factors Modify the Risk of Developing Beryllium DiseaseSeminars in Respiratory and Critical Care Medicine, 2003
- Major histocompatibility locus genetic markers of beryllium sensitization and diseaseEuropean Respiratory Journal, 2001
- Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate β69Human Immunology, 2001
- Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteinsJournal of Molecular Biology, 2000
- HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal diseaseEuropean Journal of Immunology, 1999
- HLA-DPp residue 69 plays a crucial role in allorecognitionTissue Antigens, 1998
- Interaction of genetic and exposure factors in the prevalence of berylliosisAmerican Journal of Industrial Medicine, 1997
- HLA-DPB1 Glutamate 69: a Genetic Marker of Beryllium DiseaseScience, 1993
- Maintenance of Alveolitis in Patients with Chronic Beryllium Disease by Beryllium-Specific Helper T CellsNew England Journal of Medicine, 1989
- A new force field for molecular mechanical simulation of nucleic acids and proteinsJournal of the American Chemical Society, 1984